Insights into the structural properties of SARS-CoV-2 main protease

Insights into the structural properties of SARS-CoV-2 main protease

SARS-CoV-2 is the infectious agent responsible for the coronavirus disease since 2019, which is the viral pneumonia pandemic worldwide. The structural knowledge on SARS-CoV-2 is rather limited. These limitations are also applicable to one of the most attractive drug targets of SARS-CoV-2 proteins –...

Full description

Bibliographic Details
Main Authors:	Ibrahim Yagiz Akbayrak, Sule Irem Caglayan, Lukasz Kurgan, Vladimir N. Uversky, Orkid Coskuner-Weber
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Current Research in Structural Biology
Subjects:	SARS-CoV-2 main protease Dynamics Replica exchange MD simulations
Online Access:	http://www.sciencedirect.com/science/article/pii/S2665928X22000319

Similar Items

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
by: Vishma Pratap Sur, et al.
Published: (2021-10-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Revisiting Cu(II) Bound Amyloid-β40 and Amyloid-β42 Peptides: Varying Coordination Chemistries
by: Orkid Coşkuner-Weber
Published: (2018-08-01)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
by: Menghan Gao, et al.
Published: (2023-07-01)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
by: N. Anis Ahamed, et al.
Published: (2023-12-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-06-01)

Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus <i>Aloe</i>: An In Silico Study for Drug Development
by: Mohamed E. Abouelela, et al.
Published: (2021-03-01)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
by: Lukas van de Sand, et al.
Published: (2021-04-01)

Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease
by: Márió Miczi, et al.
Published: (2020-12-01)

Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
by: Bodee Nutho, et al.
Published: (2022-01-01)

Computational approach towards the design of artemisinin–thymoquinone hybrids against main protease of SARS-COV-2
by: Victor Moreira de Oliveira, et al.
Published: (2021-09-01)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020-11-01)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
by: Pandu Hariyono, et al.
Published: (2022-01-01)

Mutations in Main Protease of SARS CoV-2 Decreased Boceprevir Affinity
by: Ekrem Akbulut
Published: (2022-02-01)

Mechanistic Insights into the Inhibition of SARS-CoV-2 Main Protease by Clovamide and Its Derivatives: In Silico Studies
by: Naike Ye, et al.
Published: (2021-09-01)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
by: Wenfa Zhang, et al.
Published: (2023-02-01)

A suitable drug structure for interaction with SARS‐CoV‐2 main protease between boceprevir, masitinib and rupintrivir; a molecular dynamics study
by: Mehdi Yoosefian, et al.
Published: (2023-09-01)

In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi
by: Mengist HM, et al.
Published: (2023-01-01)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Hylemariam Mihiretie Mengist, et al.
Published: (2021-02-01)

Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study
by: M. T. Khan, et al.
Published: (2022-04-01)

Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
by: Fangya Li, et al.
Published: (2023-06-01)

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
by: Alessandro Paciaroni, et al.
Published: (2023-03-01)

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease
by: Matthias Göhl, et al.
Published: (2022-07-01)

Characterization of host substrates of SARS-CoV-2 main protease
by: Ivonne Melano, et al.
Published: (2023-08-01)

Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
by: Dmitry S. Baev, et al.
Published: (2022-12-01)

The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus
by: Shaza S. Issa, et al.
Published: (2022-07-01)

Cotton flower metabolites inhibit SARS‐CoV‐2 main protease
by: Yufang Zhang, et al.
Published: (2022-10-01)

Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814
by: Haihai Jiang, et al.
Published: (2023-08-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation
by: Niloofar Hemati, et al.
Published: (2022-01-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01)

Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
by: Chunlong Ma, et al.
Published: (2022-04-01)

Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
by: Gordon J. Lockbaum, et al.
Published: (2021-01-01)

Exploration of Potent Antiviral Phytomedicines from Lauraceae Family Plants against SARS-CoV-2 Main Protease
by: Himashree Bora, et al.
Published: (2022-12-01)

Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
by: János András Mótyán, et al.
Published: (2022-03-01)

Synthesis of indole-based oxadiazoles and their interaction with bacterial peptidoglycan and SARS-CoV-2 main protease: In vitro, molecular docking and in silico ADME/Tox study
by: Mohammad Azam Ansari, et al.
Published: (2022-05-01)

In Silico Evaluation of Different Flavonoids from Medicinal Plants for Their Potency against SARS-CoV-2
by: H. R. Abd El-Mageed, et al.
Published: (2021-11-01)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-07-01)

Crystal structures of main proteases of SARS-CoV-2 variants bound to a benzothiazole-based inhibitor
by: Luo Jiqing, et al.
Published: (2023-06-01)